European Stocks Drop on US Medical Devices Probe; H&M Climbs

European stocks declined 0.7% on the Stoxx Europe 600 Index, with the healthcare sector falling 1.9%, after the US administration initiated investigations into imports of robotics, industrial machinery, and medical devices, signaling potential tariffs. This development highlights escalating trade tensions and their immediate negative impact on European equities, particularly in sectors exposed to US trade policy.

Analysis

European equities retreated, with the Stoxx Europe 600 Index declining 0.7%, directly in response to the US administration launching investigations into key European exports including robotics, industrial machinery, and medical devices. The market's reaction highlights the significant risk posed by escalating trade tensions. The healthcare sector was the primary driver of the downturn, falling 1.9% as the prospect of US tariffs on medical devices immediately soured investor sentiment for exposed companies. The negative pressure extended beyond healthcare, with construction and real estate stocks also underperforming, suggesting a broader risk-off sentiment is taking hold as market participants price in new geopolitical uncertainties.